Δ9-tetrahydrocannabinol
SMILES | CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C |
InChIKey | CYQFCXCEBYINGO-IAGOWNOFSA-N |
Chemical properties
Hydrogen bond acceptors | 2 |
Hydrogen bond donors | 1 |
Rotatable bonds | 4 |
Molecular weight (Da) | 314.2 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
CB1 | CNR1 | Human | Cannabinoid | A | pKi | 7.3 | 7.35 | 7.4 | Guide to Pharmacology |
CB2 | CNR2 | Human | Cannabinoid | A | pKi | 7.1 | 7.3 | 7.5 | Guide to Pharmacology |
CB1 | CNR1 | Mouse | Cannabinoid | A | pKi | 7.39 | 7.54 | 7.82 | ChEMBL |
CB2 | CNR2 | Mouse | Cannabinoid | A | pKi | 7.4 | 7.56 | 8.04 | ChEMBL |
CB2 | CNR2 | Human | Cannabinoid | A | pKi | 7.14 | 7.46 | 8.48 | ChEMBL |
CB1 | CNR1 | Human | Cannabinoid | A | pKi | 7.39 | 7.67 | 8.54 | ChEMBL |
CB2 | CNR2 | Human | Cannabinoid | A | pKi | 7.35 | 7.77 | 8.5 | PDSP Ki database |
CB2 | CNR2 | Mouse | Cannabinoid | A | pKi | 7.56 | 8.16 | 8.76 | PDSP Ki database |
CB2 | CNR2 | Rat | Cannabinoid | A | pKi | 7.55 | 7.86 | 8.17 | PDSP Ki database |
CB1 | CNR1 | Human | Cannabinoid | A | pKi | 7.82 | 7.99 | 8.3 | PDSP Ki database |
CB1 | CNR1 | Mouse | Cannabinoid | A | pKi | 8.08 | 8.08 | 8.08 | PDSP Ki database |
CB1 | CNR1 | Human | Cannabinoid | A | pKi | 8.07 | 8.07 | 8.07 | Drug Central |
CB2 | CNR2 | Human | Cannabinoid | A | pKi | 8.07 | 8.07 | 8.07 | Drug Central |
CB2 | CNR2 | Mouse | Cannabinoid | A | pKi | 8.09 | 8.09 | 8.09 | Drug Central |
CB1 | CNR1 | Mouse | Cannabinoid | A | pKi | 8.13 | 8.13 | 8.13 | Drug Central |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
GPR18 | GPR18 | Human | GPR18, GPR55 and GPR119 | A | pEC50 | 6.02 | 6.02 | 6.02 | Guide to Pharmacology |
GPR55 | GPR55 | Human | GPR18, GPR55 and GPR119 | A | pEC50 | 8.1 | 8.1 | 8.1 | Guide to Pharmacology |
GPR18 | GPR18 | Human | GPR18, GPR55 and GPR119 | A | pEC50 | 5.34 | 5.57 | 6.02 | ChEMBL |
CB1 | CNR1 | Mouse | Cannabinoid | A | pEC50 | 7.11 | 7.11 | 7.11 | ChEMBL |
CB2 | CNR2 | Mouse | Cannabinoid | A | pEC50 | 8.14 | 8.14 | 8.14 | ChEMBL |
GPR55 | GPR55 | Human | GPR18, GPR55 and GPR119 | A | pEC50 | 4.85 | 4.85 | 4.85 | ChEMBL |
GPR55 | GPR55 | Human | GPR18, GPR55 and GPR119 | A | pIC50 | 4.85 | 4.85 | 4.85 | ChEMBL |
CB2 | CNR2 | Human | Cannabinoid | A | pIC50 | 8.02 | 8.02 | 8.02 | ChEMBL |
CB2 | CNR2 | Human | Cannabinoid | A | pEC50 | 7.91 | 8.22 | 8.82 | ChEMBL |
CB1 | CNR1 | Human | Cannabinoid | A | pEC50 | 7.11 | 7.42 | 7.77 | ChEMBL |
CB1 | CNR1 | Human | Cannabinoid | A | pIC50 | 8.55 | 8.55 | 8.55 | ChEMBL |
GPR18 | GPR18 | Human | GPR18, GPR55 and GPR119 | A | pEC50 | 8.22 | 8.22 | 8.22 | Drug Central |
D3 | DRD3 | Human | Dopamine | A | pEC50 | 7.99 | 7.99 | 7.99 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pEC50 | 8.1 | 8.1 | 8.1 | Drug Central |
GPR55 | GPR55 | Human | GPR18, GPR55 and GPR119 | A | pIC50 | 8.31 | 8.31 | 8.31 | Drug Central |